Replies to post #398078 on Innovation Pharmaceuticals Inc (IPIX)

[frenchbroad]

Doesn't matter...he has successfully dangled another carrot.

If I understand correctly your message is Mr. Ehrlich wants Ipix investors to believe something not true about Brilacidin potential as anti-fungus therapy.

These universities and governments and scientists are not "dangling a carrot". They only find what Brilacidin can do and show the world the proof.
https://www.nature.com/articles/s41467-023-37573-y
https://static1.squarespace.com/static/5715352e20c647639137f992/t/6410cf60bf82b22d43f5682c/1678823268392/BRI+Keratitis+GRC+poster+1.31.23.pdf
https://www.ipharminc.com/press-release/2023/3/15/innovation-pharmaceuticals-announces-new-antifungal-testing-of-brilacidin-by-nihniaid-affiliated-and-other-academic-researchers